News search

About the CNIC

15 Sep 2017

A benefactor names the CNIC his universal heir

Philanthropy, a way to connect individuals with institutions dedicated to research that increase the quality of life and improve society, is an act of generosity not sufficiently recognized today

From left to right. Vicente Andres, Director of Basic Research of the CNIC; Mr. Makoto Suematsu, the President of the Japanese Agency for Research and Medical Development (AMED); Borja Ibáñez, Director of Clinical Research at the CNIC; Mr. Masahiko Noda, Managing Director of the Foreign Affairs Department, Alberto Sanz, Managing Director of the CNIC, and the First Secretary - Aggregate of Science and Technology – of the Japanese Embassy in Spain, Mr. Masahiro Aoki

About the CNIC

13 Sep 2017

The Japanese Agency for Research and Medical Development at the CNIC

The Japanese Agency for Research and Medical Development (AMED) is an institution dedicated to improving medicine through research and development in Japan

Photo 1: The authors are holding in their hands illustrations of cells expressing different combinations of membrane and nuclei fluorescent proteins. This corresponds to the method we developed (present in the article) to differentially label cells expressing different genes (with the codes A to F). Each cell expresses a different combination of 2 genes from a pool of 6 different genes (A, B, C, D, E, and F).

Publications

10 Aug 2017

Cell: CNIC Scientists develop new methods for analyzing gene function

The study, published in Cell, will allow any researcher to induce multispectral genetic mosaics in vertebrate research models such as mice and zebrafish

3D ultrasound of the right carotid artery. An atherosclerotic plaque is visible as a small protrusion (arrow) in the vessel wall of the internal branch of the proximal carotid artery (bottom), close to the bifurcation. In contrast, the surface of the disease-free external branch (top) is smooth (asterisk).

Research

24 Jul 2017

'JACC': 3D visualization of cholesterol plaques improves cardiovascular risk prediction

CNIC researchers show the value of total atherosclerosis burden for the identification of individuals at risk of cardiovascular disease

About the CNIC

27 Jun 2017

Eduardo Oliver, awarded the Young Researcher Award of the Spanish Society of Pharmacology

The Young Researcher Award of the Spanish Society of Pharmacology (SEF) is awarded to members of the SEF under 35 years of age with the best scientific career

About the CNIC

1 Jun 2017

Dr. Borja Ibáñez awarded the XII Banco Sabadell Foundation Award for Biomedical Research

Dr. Ibáñez, Director of Clinical Research at the CNIC, has received an award for his contribution to the fight against cardiovascular diseases

Alberto Sanz, Gerente del CNIC; Dr. Jordi Camí, director de la Fundación Pasqual Maragall; Dr. Valentín Fuster, director general del CNIC, y Dr. Borja Ibáñez, Director de Investigación Clínica del CNIC.

About the CNIC

30 May 2017

Two of the of the largest research cohorts in Spain join together to work on the prevention of atherosclerosis and Alzheimer’s

Los resultados permitirán avanzar en el conocimiento de la interacción entre los diversos factores de riesgo de ambas enfermedades

The Commissioner of Health and Food Safety of the European Commission, Vytenis Andriukaitis, during his visit at CNIC.

About the CNIC

3 May 2017

Health and Food Safety Commissioner from the European Commission visits CNIC

The Health and Food Safety Commissioner from the European Commission, Vytenis Andriukaitis, visited Carlos III National Centre of Cardiovascular Research (CNIC)